Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
NBTXR3 + Radiation and Immunotherapy for Metastatic Lung Cancer
Recruiting1 awardPhase 1 & 2
Houston, Texas
This trial is testing a combination of drugs and therapies to treat patients with solid tumors that have spread to the lung or liver. The hope is that the combination will be more effective than any one treatment alone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.